CLINICAL_TRIALS
trial_result
· 2017-06-14
Clinical Trial Update: Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease [Phase 2]
Summary
Phase 2 trial evaluating whether vitamin D modulates serum hepcidin in children with anemia of chronic kidney disease; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Anemia of Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-06-14